Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension
NCT00741078 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2008-08-29
Summary
The investigators hypothesized combination therapy would be superior to monotherapy.
Conditions
Interventions
- DRUG
-
statin, amlodipine
Sponsors & Collaborators
-
Gachon University Gil Medical Center
lead OTHER
Study Design
- Purpose
- TREATMENT
- Model
- CROSSOVER
Eligibility
- Min Age
- 25 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-12-31
- Completion
- 2008-08-31
Countries
- South Korea
Study Locations
More Related Trials
-
The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients
NCT03785509 ·Status: COMPLETED
-
Simvastatin in Patients With Isolated Arterial Hypertension
NCT01017835 ·Status: UNKNOWN
-
Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients
NCT01040936 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Atorvastatin in Patients With Atherosclerosis
NCT00115817 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man
NCT01214746 ·Status: COMPLETED ·Phase: PHASE2
-
High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients
NCT05912686 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Effect of Statin Use on Vascular Function in Hypertensive Subjects
NCT00181181 ·Status: TERMINATED ·Phase: PHASE4
-
Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome
NCT00728988 ·Status: COMPLETED ·Phase: PHASE4
-
Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease
NCT01187992 ·Status: TERMINATED ·Phase: PHASE3
-
Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
NCT02590653 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease
NCT01946815 ·Status: COMPLETED ·Phase: PHASE3
-
Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill
NCT01073800 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Atorvastatin Plus Ezetimibe on Coronary Plaque Progression
NCT01086020 ·Status: UNKNOWN ·Phase: PHASE4
-
A Pilot Study Exploring Efficacy and Safety of Amlodipine in the Stented Angina Patients
NCT01120327 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Atorvastatin on Atherosclerosis Composition
NCT00576576 ·Status: COMPLETED ·Phase: NA
-
Single Dose of Atorvastatin and Circulating Endothelial Microparticles
NCT02023892 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Atorvastatin on Carotid Intima Media Thickness
NCT04306627 ·Status: UNKNOWN ·Phase: PHASE4
-
Atorvastatin for Prevention of Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting Surgery
NCT00611143 ·Status: COMPLETED ·Phase: NA
-
Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome
NCT01372839 ·Status: UNKNOWN ·Phase: PHASE4
-
Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention
NCT06281041 ·Status: COMPLETED
-
Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease
NCT00770575 ·Status: COMPLETED ·Phase: PHASE2
-
Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
NCT01761656 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Effects of High-dose Statin and Trimetazidine on Patients With Aspirin Mono Antiplatelet Therapy 12-months After Coronary Artery Bypass Surgery
NCT01857921 ·Status: COMPLETED ·Phase: NA
-
Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation
NCT01557075 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy
NCT01213498 ·Status: COMPLETED ·Phase: PHASE2